Opioid Use Disorder Treatment National Institute on Drug Abuse NIDA

Thus, the NIH and FDA have recently called for consideration of meaningful study endpoints in addition to abstinence in research on new smoking-cessation products6; though abstinence is still required as the main outcome for medication approval. Published in The New England Journal of Medicine, the study analyzed data from 6,400 people with probable opioid use disorder who were incarcerated in seven Massachusetts county jails between September 2019 and December 2020. Researchers monitored treatment engagement, opioid overdose, reincarceration, and mortality for all participants for up to six months after release. When taken as prescribed by a person with a substance use disorder, medications control withdrawal symptoms and cravings and, over time, help restore balance to brain circuits that have been affected by addiction, and they are not addictive themselves. Behavioral therapies help people in drug addiction treatment modify their attitudes and behaviors related to drug use.

About the NIH HEAL Initiative

Indeed, depending on the conditions a patient is diagnosed with, healthcare providers may need to balance the prescription of necessary medications with risk of addiction to those same medications, as may be the case for patients with OUD and chronic pain. Therefore, treating OUD patients with medical comorbidities often requires a multidisciplinary approach that may involve addiction counselors, other mental health professionals, pain specialists, and other providers. Research is needed to develop optimal treatments and treatment delivery models for this population. Buprenorphine is another opioid medication that is used to treat opioid use disorder.

A person who has a severe substance use disorder, also known as addiction, finds it very hard or even impossible to control their drug use. Additionally, medications are used to help people detoxify from drugs, although detoxification is not the same as treatment and is not sufficient to help a person recover. Detoxification alone without subsequent treatment generally leads to resumption of drug use.

Other NIDA Sites

Researchers collected data directly from incarcerated individuals and extracted information from jail administrative and clinical records. These data were integrated with the Massachusetts Public Health Data Warehouse, which links over 35 state databases to track treatment for substance use disorders, incarceration, mortality, and other public health indicators. This linkage enabled a robust analysis of the program’s impact on key post-release outcomes. The opioid epidemic remains a devastating public health challenge in the United States, contributing to more than 80,000 deaths in 2024 alone. People with opioid use disorder are overrepresented in jails compared to the general population. Despite their effectiveness, MOUD is available in only about 13% of U.S. jails and is often restricted to specific groups, such as pregnant women.

There is little scientific evidence to support the stereotype that people who return to use after a period of abstinence inevitably do so at the same intensity. Some research on post-treatment patterns of alcohol and other drug use in adolescents suggests that returns to use, when they occur, are often at a lower intensity than before11. People in recovery sometimes draw a distinction between resumption of a heavy and compulsive use pattern and isolated, one-time returns to substance use, recognizing that brief “slips” or “lapses” don’t need to be catastrophic to recovery efforts and may even strengthen the person’s resolve to recover.

What are the principles of effective treatment?

Behavioral counseling is typically provided by specialists in smoking cessation for four to eight sessions.40 Both in-person and telephone counseling have been found beneficial for patients who are also using cessation medications.164 A variety of approaches to smoking cessation counseling are available. Mutual help groups are peer-led recovery organizations that provide fellowship and support to people with substance use disorders by connecting https://22betofficial.com/ them to peers who are in recovery. These include 12-step programs such as Alcoholics Anonymous and Narcotics Anonymous and others such as SMART Recovery, Women in Sobriety, and Life Ring. Because addiction can affect so many aspects of a person’s life, treatment should address the needs of the whole person to be successful. Counselors may select from a menu of services that meet the specific medical, mental, social, occupational, family, and legal needs of their patients to help in their recovery.

• Mutual help groups are peer-led recovery organizations that provide fellowship and support to people with substance use disorders by connecting them to peers who are in recovery.
• Behavioral counseling is typically provided by specialists in smoking cessation for four to eight sessions.40 Both in-person and telephone counseling have been found beneficial for patients who are also using cessation medications.164 A variety of approaches to smoking cessation counseling are available.
• NIDA is a biomedical research organization and does not provide personalized medical advice, treatment, counseling, or legal consultation.
• There are effective treatments that support tobacco cessation, including both behavioral therapies and FDA-approved medications.
• NIDA has led more than half of this work, with an investment of $2.1 billion in 1,200 research projects since the inception of HEAL.

Research is needed to develop interventions to prevent and treat polysubstance use and related overdoses. The FDA has historically favored abstinence as the endpoint in trials to develop medications for substance use disorders. Abstinence has been evaluated using absence of positive urine drug tests, absence of self-reported drug use, and regularly attending sessions where drug use is assessed.

When people enter treatment, addiction has often caused serious consequences in their lives, possibly disrupting their health and how they function in their family lives, at work, and in the community. These research objectives incorporate other cross-cutting goals, including enhancing women’s and children’s health; addressing public health challenges across the lifespan; promoting collaborative science; and leveraging data science for biomedical discovery. For many people trying to recover from a substance use disorder, perhaps for the majority, abstinence may be the most appropriate treatment objective. But complete abstinence is sometimes not achievable, even in the long-term, and there is a need for new treatment approaches that recognize the clinical value of reduced use. They have screening tools and can refer you to treatment or other services if needed. A return to drug use is an indication that a person should speak to their healthcare provider about resuming or modifying their treatment plan.

While relapse is a normal part of recovery, for some drugs, it can be very dangerous—even deadly. If a person uses as much of the drug as they did before quitting, they can easily overdose because their bodies are no longer adapted to their previous level of drug exposure. An overdose happens when the person uses enough of a drug to produce uncomfortable feelings, life-threatening symptoms, or death. Like treatment for other chronic diseases such as heart disease or asthma, addiction treatment is not a cure, but a way of managing the condition. Treatment enables people to counteract addiction’s disruptive effects on their brain and behavior and regain control of their lives.